| Reduced prevalence of SARS-CoV-2 infection in ABO blood group O MB Barnkob, A Pottegård, H Støvring, TM Haunstrup, K Homburg, ... Blood advances 4 (20), 4990-4993, 2020 | 179 | 2020 |
| Emerging approaches for regulation and control of CAR T cells: a mini review LJB Brandt, MB Barnkob, YS Michaels, J Heiselberg, T Barington Frontiers in Immunology 11, 513684, 2020 | 85 | 2020 |
| BioReader: a text mining tool for performing classification of biomedical literature C Simon, K Davidsen, C Hansen, E Seymour, MB Barnkob, LR Olsen BMC bioinformatics 19, 165-170, 2019 | 77 | 2019 |
| Precise tuning of gene expression levels in mammalian cells YS Michaels, MB Barnkob, H Barbosa, TA Baeumler, MK Thompson, ... Nature communications 10 (1), 818, 2019 | 61 | 2019 |
| Differential requirement for CD70 and CD80/CD86 in dendritic cell-mediated activation of tumor-tolerized CD8 T cells SP Bak, MS Barnkob, A Bai, EM Higham, KD Wittrup, J Chen The Journal of Immunology 189 (4), 1708-1716, 2012 | 49 | 2012 |
| cyCombine allows for robust integration of single-cell cytometry datasets within and across technologies CB Pedersen, SH Dam, MB Barnkob, MD Leipold, N Purroy, LZ Rassenti, ... Nature communications 13 (1), 1698, 2022 | 36 | 2022 |
| Bioinformatics for cancer immunotherapy target discovery LR Olsen, B Campos, MS Barnkob, O Winther, V Brusic, MH Andersen Cancer immunology, immunotherapy 63, 1235-1249, 2014 | 28 | 2014 |
| Chromatin accessibility governs the differential response of cancer and T cells to arginine starvation NT Crump, AV Hadjinicolaou, M Xia, J Walsby-Tickle, U Gileadi, JL Chen, ... Cell Reports 35 (6), 2021 | 27 | 2021 |
| Characterizing the human hematopoietic CDome MS Barnkob, C Simon, LR Olsen Frontiers in Genetics 5, 110333, 2014 | 13 | 2014 |
| Harnessing the immune system to fight multiple myeloma J Krejcik, MB Barnkob, CG Nyvold, TS Larsen, T Barington, N Abildgaard Cancers 13 (18), 4546, 2021 | 12 | 2021 |
| Post-translational proteomics platform identifies neurite outgrowth impairments in Parkinson’s disease GBA-N370S dopamine neurons H Bogetofte, BJ Ryan, P Jensen, SI Schmidt, DLE Vergoossen, ... Cell Reports 42 (3), 2023 | 9 | 2023 |
| Antibody response following the third and fourth SARS-CoV-2 vaccine dose in individuals with common variable immunodeficiency BU Nielsen, CH Drabe, MB Barnkob, IS Johansen, AKK Hansen, ... Frontiers in immunology 13, 934476, 2022 | 8 | 2022 |
| Target isoforms are an overlooked challenge and opportunity in chimeric antigen receptor cell therapy M Bogetofte Barnkob, K Vitting-Seerup, L Rønn Olsen Immunotherapy Advances 2 (1), ltac009, 2022 | 8 | 2022 |
| Nucleotide composition of human Ig nontemplated regions depends on trimming of the flanking gene segments, and terminal deoxynucleotidyl transferase favors adding cytosine, not … T Funck, MB Barnkob, N Holm, L Ohm-Laursen, CS Mehlum, S Möller, ... The Journal of Immunology 201 (6), 1765-1774, 2018 | 4 | 2018 |
| Semaphorin 3A induces cytoskeletal paralysis in tumor-specific CD8+ T cells MB Barnkob, YS Michaels, V André, PS Macklin, U Gileadi, S Valvo, ... BioRxiv, 849083, 2019 | 2 | 2019 |
| Software-supported selection of cell surface proteins for cell stratification and chimeric antigen receptor-based therapies C Simon, B Mike, LR Olsen Blood 124 (21), 5116, 2014 | 1 | 2014 |
| Semmaphorin 3 A causes immune suppression by inducing cytoskeletal paralysis in tumour-specific CD8+ T cells MB Barnkob, YS Michaels, V André, PS Macklin, U Gileadi, S Valvo, ... Nature Communications 15 (1), 3173, 2024 | | 2024 |
| Severe lympho-depletion, abrogated thymopoiesis and systemic EBV positive T-cell lymphoma of childhood, a case A Asmussen, L Quintanilla-Martinez, M Larsen, C Fagerberg, ... Leukemia & Lymphoma 65 (1), 118-122, 2024 | | 2024 |
| Tools for systematic evaluation of novel chimeric antigen receptor therapy targets G Moranzoni, CK Lemvigh, MB Barnkob, LR Olsen | | 2022 |
| Assessment of CD19 exon 2 abundance as a proxy for CD19delta expression and prediction of anti-CD19 CAR therapy relapse SH Dam, MB Barnkob, K Vitting-Seerup 10th Annual Immuno-Oncology Summit, 2022 | | 2022 |
